Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AI and Machine Learning
Biotech
OpenAI launches biotech-specific AI model dubbed GPT-Rosalind
OpenAI is introducing a new reasoning model, GPT-Rosalind, to support research in biology, drug discovery and translational medicine.
Will Maddox
Apr 17, 2026 10:00am
Small pools, big ideas: Rare disease community reimagines trials
Apr 17, 2026 3:00am
Fierce Pharma
Novartis CEO Vas Narasimhan joins Anthropic's board
Apr 15, 2026 10:36am
Fierce Pharma
Novo becomes latest drugmaker to strike OpenAI pact
Apr 14, 2026 10:13am
'Can it deliver?': Why Big Pharma has entered the quantum realm
Apr 10, 2026 7:20am
Lilly embraces AI biotech Insilico again, inking $2.75B collab
Mar 29, 2026 8:00pm